These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Payer cost savings with endometrial ablation therapy. London R; Holzman M; Rubin D; Moffitt B Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409 [TBL] [Abstract][Full Text] [Related]
3. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Dickersin K; Munro MG; Clark M; Langenberg P; Scherer R; Frick K; Zhu Q; Hallock L; Nichols J; Yalcinkaya TM; Obstet Gynecol; 2007 Dec; 110(6):1279-89. PubMed ID: 18055721 [TBL] [Abstract][Full Text] [Related]
4. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Bourdrez P; Bongers MY; Mol BW Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006 [TBL] [Abstract][Full Text] [Related]
5. Current treatment of dysfunctional uterine bleeding. Bongers MY; Mol BW; Brölmann HA Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486 [TBL] [Abstract][Full Text] [Related]
6. Endometrial ablation with NovaSure GEA, a pilot study. Busund B; Erno LE; Grønmark A; Istre O Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843 [TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding. Hawe J; Abbott J; Hunter D; Phillips G; Garry R BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795 [TBL] [Abstract][Full Text] [Related]
9. The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding. Munro MG; Dickersin K; Clark MA; Langenberg P; Scherer RW; Frick KD; Menopause; 2011 Apr; 18(4):445-52. PubMed ID: 21701431 [TBL] [Abstract][Full Text] [Related]
10. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Frick KD; Clark MA; Steinwachs DM; Langenberg P; Stovall D; Munro MG; Dickersin K; Womens Health Issues; 2009; 19(1):70-8. PubMed ID: 19111789 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of treatments for dysfunctional uterine bleeding. Wade SW; Magee G; Metz L; Broder MS J Reprod Med; 2006 Jul; 51(7):553-62. PubMed ID: 16913546 [TBL] [Abstract][Full Text] [Related]
12. Uterine artery embolization as a treatment option for uterine myomas. Marshburn PB; Matthews ML; Hurst BS Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811 [TBL] [Abstract][Full Text] [Related]
13. [Endometrial ablation versus hysterectomy in women treated with tamoxifen]. Capuano I; Caporale A; Vagnetti P; Di Domenico A; Felicetti M; Torella M; Borrelli AL Minerva Ginecol; 2007 Oct; 59(5):499-504. PubMed ID: 17912176 [TBL] [Abstract][Full Text] [Related]
14. Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB): design and methods. Dickersin K; Munro M; Langenberg P; Scherer R; Frick KD; Weber AM; Johns A; Peipert JF; Clark M; Control Clin Trials; 2003 Oct; 24(5):591-609. PubMed ID: 14500057 [TBL] [Abstract][Full Text] [Related]